Purchase 2-A1MP
Discount program, second order - 5% OFF, third order - 7% OFF
With us securely! - re-shipment guarantees.
We always offer new legal products of impeccable quality.
Please make sure that the product is legal in your country and not under control before ordering.
We do not sell pharmaceutical products or controlled products.
Where to buy 2-A1MP for sale
2-A1MP is a chemical compound of the cathinone class sold online as a designer drug. It is the beta-ketone version of 5-Methoxy-MDMA. The more common name 2-AIMP/2-A1MP does not relate to the molecular structure. Compared with methylone, the two compounds differ by adding a methoxy group at the 5th carbon atom of the aromatic ring.
2-A1MP is a chemical compound of the cathinone class sold online as a designer drug. The substance is the beta-ketone version of 5-Methoxy-MDMA. Unlike methylone, the two compounds differ by adding a methoxy group at the 5th carbon atom of the aromatic ring.
2-AIMP/2-A1MP is a chemical compound of the cathinone class sold online as a designer drug. It is similar in structure to methylone and MDPV except with a methoxy group attached to the 5th carbon of the aromatic ring.
2-A1MP is a chemical compound belonging to the class of compounds called beta-ketone derivatives of Cathinones. The beta-ketone analogue, or derivative, of 5-methoxy-MDMA (Methylone). The more commonly known name 2-A1MP does not relate to structure and maybe a spelling variant.
2-A1MP (2-aminoindan-1-one, 2-(2-aminoethenyl)-1-methyl-propan-2-one) is a synthetic stimulant of the cathinone class. It is a structural analogue of amphetamine where the alpha carbon (carbon number 1) has been replaced with an amino group, and a methylenedioxy group has been added at the five positions of the phenyl ring.
2-amino-1-methyl-6-(2-phenylmethyl)-4H-indol-4-one is an indole, a tryptamine and amphetamine derivative which acts as a cannabinoid agonist at both the CB 1 and CB 2 receptors. It is structurally related to the psychedelic tryptamines psilocin, the precursor of 4-AcO-DMT, and DMT.
2-A1MP, also known as 2-AIMP and 2-A1MP, is a designer drug of the cathinone class. It is the beta-ketone version of 5-Methoxy-MDMA. The more common name 2-AIMP/2-A1MP does not relate to its molecular structure. Compared with methylone, the two compounds differ by adding a methoxy group at the common 5th carbon atom of their aromatic ring.
2-A1MP (also known as 2-ammdimethylone, 5-methoxy-2a-methyl-6-(3-methoxyphenyl)- 4, 4, 6-trimethylenedioxy amphetamine) is a chemical compound of the cathinone class. It belongs to substituted amphetamines and substituted phenethylamines, respectively. The compound is closely related to methylone and was first made by chemists at Purdue University in 2014 for research purposes.
2-A1MP is a compound that is in the class of substituted amphetamines. It was first synthesized by chemists at Purdue University and was later tested on animals.
The first drug was 2-A1MP, which has two methylenedioxy groups (methoxy groups adjacent to the amine group) instead of just one, thus being a dimethylone as opposed to methylone.
Developed by our experienced specialists, the best 2-A1MP is delivered in high-quality powder and crystals. Once you place an order, our product delivery time starts. The products are packed and ready for shipment in special foil packages in a vacuum atmosphere to avoid moisture degradation.
2-A1MP, better known as 2-amino in an or 2-aminoindane, is a designer drug. Unlike most research chemicals and amphetamines, 2-A1MP doesn't seem particularly potent or carry any potential for abuse.
To prepare the content, the following materials were used:
- FDA Substance Registration System
- Hazardous Substances Data Bank. National Library of Medicine. 28 August 2008. Retrieved 22 August 2014. 3,4-Methylenedioxymethamphetamine
- Liver transplant modulates gut microbial dysbiosis and cognitive function in cirrhosis. PDF . By HoChong Gilles, Scott C Matherly, Mohammed S Siddiqui, Puneet Puri...
- Differential impact of hyponatremia and hepatic encephalopathy on health-related quality of life and brain metabolite abnormalities in cirrhosis . By Jasmohan Bajaj
- An overview of alcohol and other drug issues
- Medicating the mind: a Kantian analysis of overprescribing psychoactive drugs B A Manninen
- The pharmacological basis of opioids Carla Ghelardini, Lorenzo Di Cesare Mannelli and Enrica Bianchi
- Ask Dr. Shulgin Online ARCHIVE: June 3, 2004
- Inhibition of plasma membrane monoamine transporters by β-ketoamphetamines. Nicholas V Cozzi, Michael KSievert, Alexander T Shulgin, Peyton JacobIII, Arnold Eruoho
- Schedules of Controlled Substances: Placement of Methylone Into Schedule I
- Bioanalysis of new designer drugs. Wohlfarth A, Weinmann W.
- New Psychoactive Substances (including synthetic cannabinoids, mephedrone, and more)
- Future Synthetic Drugs of Abuse. Donald A. Cooper. Drug Enforcement Administration McLean, Virginia
- Designer drugs: a medicinal chemistry perspective. F. Ivy Carroll Anita H. Lewin S. Wayne Mascarella Herbert H. Seltzman P. Anantha Reddy
- Synthetic cannabinoids in Europe
- Pharmacological Effects of MDMA in Man. By Enno Freye
- Drug Use in Relation to Outcome of Mammography Screening. von Euler-Chelpin M, Wu W, Vejborg and Lynge E
- DEA Drug Scheduling
- Electrophysiological Effects of Trace Amines on Mesencephalic Dopaminergic Neurons.Ada Ledonne, Nicola Berretta, Alessandro Davoli, Giada Ricciardo Rizzo, Giorgio Bernardi and Nicola Biagio Mercuri
- Electrophysiological evidence for a reciprocal interaction between amphetamine and cocaine-related drugs on rat midbrain dopaminergic neurons.Scarponi M, Bernardi G, Mercuri NB.
- Overdose of Drugs for Attention-Deficit Hyperactivity Disorder: Clinical Presentation, Mechanisms of Toxicity, and Management. Henry A. Spiller, author Hannah L. Hays Alfred Aleguas.
- Dose-dependent effectiveness of wheel running to attenuate cocaine-seeking: impact of sex and estrous cycle in rats. Peterson AB, Hivick DP, Lynch WJ.r.
- FDA Drug Safety Communication: Safety Review Update of Medications used to treat Attention-Deficit/Hyperactivity Disorder (ADHD) in children and young adults
- ADHD Medications and Risk of Serious Cardiovascular Events in Young and Middle-aged Adults
- Controlled Substances Act
- The Art of Drug Synthesis (Wiley Series on Drug Synthesis)
- Cannabis: domestic cultivation widespread
- A review of the influence of functional group modifications to the core scaffold of synthetic cathinones on drug pharmacokinetics
500g $1700
-min-200x127.JPG)
1kg $1690
100g $390
1kg $2400
1kg $1590
500g $1080
500g $1390
500g $1080
500g $1080
100g $580
1kg $1690
100g $500